Member Info for Bobber69

In the meantime, I'm hoping Unilever will be looking at first mover advantage on the malodour front.

IMO the market remains cautious over the cash position. We know they have enough cash to last into 2026. However, with a cash burn of ~300k/month. It means substantial licence fees or an upfront payment will be required to avoid another placing.

The fee for service contracts alone are not able to generate a positive cashflow.

Fantastic update. I especially liked the use of the term 'magic bullet' and the acknowledgement that there are 'no current treatments able to reverse the damage'.

Looks like whoever was selling big-ish chunks doesn't want to do so below 0.3p, so probably a good time to buy.

I'm expecting a really positive trading update and reinforcement of the cash position.

End of the APTA financial year is coming up in the next week or so. Should get a trading update around the same time.

'Not nervous and quite comfortable'.......has Suzy hacked your account? 😉

Today's fee-for-service contracts means that cash pipeline has now extended beyond June 2026.

I anticipate further similar contracts being announced in the next twelve months, which will extend this runway even further; To a point where regular licence payments are being received.

The directors first set of options kicks in at 1.4p, so this is still a steal.

Fantastic news.

Well done to the whole Aptamer team.

It's great to see the relationship between APTA and Unilever developing so quickly and strongly. They clearly see the game changing science aptamers can bring to their business.

Why would you even want to contemplate TO at this stage of development?

I'd like to think the MCAP would be multiple times of what it is now, before that possibility is raised.

I'm assuming the cash burn is still ~£300k/month. Need more RNS's like the one this morning, before the licencing fees kick in.

The imminent trading update should reinforce the solid cash position.

Hopefully, confirmation of more fee-for-service contracts announced at the same time, to bolster this.

The recently appointed NED is taking his salary in APTA stock. No worries on that front.

I've been surprised there has been no presentation following the two recent news releases, considering their importance. Makes me think there is more to come.

That's probably the underhanded AIM for you. I can't say I'm surprised after the dip into the 0.2-0.3p range.

Should see a continued rise when the people selling into this news are done.

Would be nice to know if Arron would consider moving to a proper trading platform eventually.

Be interesting to see where the MMs open this today.

No other non-invasive test like this available in the world.

This is ground-breaking technology.

This is a fantastic piece of news.

Hopefully, we'll soon see some mainstream press in relation to the test.

Well done to the team at Aptamer.

Another commercial revenue stream to start in 12-18 months!

There can't be many companies with a MCAP even close to Aptamers, who have working relationships with all the top 10 global pharmas.

Looking forward to an interview following yesterday's RNS. Hopefully, Arron can shed a bit more light on the licencing agreement and garner a bit more interest in the company as a result.

Possibly the last chance to buy under 0.4p today! 👍

Excellent RNS from Aptamer today. Regardless of how much they will earn from the licencing agreement and by when, it demonstrates they have an in demand commodity, with the ability to translate into revenue.

Also interesting that the agreement is global and they expect the Uni to commercialise in the next twelve months. 👍

Be interesting to see when the salary for stock arrangement comes to an end. Could very well be the first indication a licencing deal is imminent.

In my opinion, SH's couldn't have got a more positive statement as to the future of the company than Tim Sykes willingness to receive his salary in lieu of stock after being a NED for only a matter of weeks.

On top of this we know there is a cash runway into 2026, by which time licence fees should start being received.